Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.

Published byAugusta Wood Modified over 6 years ago

Similar presentations

Presentation on theme: "Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with."— Presentation transcript:

1 Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure  Todd Dardas, MD, MS, Yanhong Li, MD, MS, Shelby D. Reed, PhD, Christopher M. O’Connor, MD, David J. Whellan, MD, Stephen J. Ellis, PhD, Kevin A. Schulman, MD, William E. Kraus, MD, Daniel E. Forman, MD, Wayne C. Levy, MD  The Journal of Heart and Lung Transplantation  Volume 34, Issue 8, Pages (August 2015) DOI: /j.healun Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

2 Figure 1  Predicted Seattle Heart Failure Model vs observed Kaplan-Meier survival plotted by quintiles of Seattle Heart Failure Model survival at (Top) 1-year and (Bottom) 3 years. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

3 Figure 2  Area under the receiver operator characteristic (ROC) curves (Harrell’s C) for the Seattle Heart Failure Model (SHFM) survival over 1 year of follow-up (Top) with the addition of individual cardiopulmonary exercise testing (CPET) variables and (Bottom) with the addition of the 6-minute walk distance (6MWD) and multivariable models. CPXDUR, cardiopulmonary exercise duration; Ve/Vo2, expired volume per unit time/volume of carbon dioxide slope. The Journal of Heart and Lung Transplantation  , DOI: ( /j.healun ) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

Download ppt "Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with."

Similar presentations

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.
Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,
Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,
Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States Shital Kamble, PhD, Kevin A. Schulman, MD, Shelby.

Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States Shital Kamble, PhD, Kevin A. Schulman, MD, Shelby.
Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I

Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I
Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation  Stijn E. Verleden, PhD, David Ruttens, MD, Elly Vandermeulen,

Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation  Stijn E. Verleden, PhD, David Ruttens, MD, Elly Vandermeulen,
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304  Martin J. Edelman, MD, Lydia.

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB   Martin J. Edelman, MD, Lydia.
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates  Anthony Castleberry, MD, MMCI, Michael S. Mulvihill,

The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates  Anthony Castleberry, MD, MMCI, Michael S. Mulvihill,
Patterns and Predictors of Physical Functional Disability at 5 to 10 Years After Heart Transplantation  Kathleen L. Grady, PhD, RN, David C. Naftel, PhD,

Patterns and Predictors of Physical Functional Disability at 5 to 10 Years After Heart Transplantation  Kathleen L. Grady, PhD, RN, David C. Naftel, PhD,
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.
Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.

Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device  David Dobarro, MD, Marian Urban, MD, Karen.
James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L
Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?  Wayne C. Levy,
Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study  Waldemar.
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation  Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.
Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:

Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score 
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Similar presentations

Ads by Google